The activated pancreatic stellate cells of patients with pancreatic cancer express high levels of autophagy markers, extracellular matrix (ECM) proteins and interleukin-6 (IL-6), and the greater production of these proteins is associated with worse prognosis, shorter survival and higher risk of recurrence 14, 15. The gene discussed is IL6; the disease is pancreatic neoplasm.